Deep Brain Stimulation

Physiologist John Stein on Parkinson’s disease, the applications of deep brain stimulation, and its side effects

faq | February 2, 2017

Deep Brain Stimulation (DBS) is electrical stimulation of structures deep inside the brain by inserting an electrode through the scalp, skull and cerebral cortex and delivering electrical pulses in order to alleviate various conditions, the most common of which is Parkinson’s disease (PD). This condition is due to degeneration of nerve cells in the brain’s ‘basal ganglia’, which causes tremor, rigid muscles and inability to move at will (akinesia).

Insertion of electrode during surgery using a stereotactic frame /

Insertion of electrode during surgery using a stereotactic frame /

History of the Term

We can trace the history of knowledge about the electrical activity of the nervous system all the way back to Roman times. In 15 A.D. the emperor Tiberius observed one of his freed slaves to step on an electric eel. He noticed that the eel’s electric shock caused the slave’s muscles to contract. So it became well known from these earliest times that the brain worked electrically.

Neuropsychologist Barbara Sahakian on cognitive training, areas of the brain that get affected in Alzheimer's disease, and improving cognitive function through games
In the 18th century people like Benjamin Franklin in England, then USA, Luigi Galvani in Italy, Pierre Flourens in France were experimenting using electrical currents to stimulate various parts of the brain. Probably, the most celebrated was stimulating the part of the brain called the ‘motor cortex’ and getting movements of the limbs. It was carried out first of all by Fritsch and Hitzig in Germany and then by David Ferrier in the UK. That led to the development of means of targeting different structures deep in the brain, using so called ‘stereotaxic frames’. The first one was developed in London by Horsley and Clarke and that was used to stimulate deep structures in the brain right up to the 1940s. Spiegel produced a better frame in 1947, which has become the basis for all the frames used today.

Motor Cortex / Neuroscientifically Challenged (

Motor Cortex / Neuroscientifically Challenged (

Perhaps, the most important advance thereafter was the development by Medtronics of a stimulator that could be implanted in the body. Medtronics started by making pacemakers for stimulating the heart. They then developed their cardiac pacemakers further for stimulating parts of the brain. In the 1980s Irving Cooper did a lot of experiments in humans to see whether stimulation could be used to alleviate various conditions. But none of this was very easy to carry out in those days, and what’s more the success of a new drug treatment for Parkinson’s disease, namely L-DOPA (which replaces the chemical that is missing in Parkinson’s disease), made it impractical to continue to develop DBS. But soon it became clear that L-DOPA treatment in Parkinson’s disease was not a permanent solution. By this time in the hands of Mahlon Delong, Alan Crossman and Tipu Aziz, much more was known about the pathophysiology of the basal ganglia in Parkinson’s disease. It was established that stimulating two structures deep in the basal ganglia, the globus pallidus internus and the subthalamic nucleus, were likely to be beneficial. So DBS emerged again. In Grenoble, France, Louis Benabid began stimulating the thalamus for alleviating tremor in PD, and later in the UK Tipu Aziz began targeting the globus pallidus and subthalamic nucleus with often dramatic improvements in Parkinson’s symptoms. Now worldwide, more than 150,000 Parkinsonian patients have received DBS for alleviation of their Parkinson’s symptoms

How It Works

The surgeon decides first of all where in the brain he wants to stimulate. If you are doing DBS you have to be able to target your electrode very precisely to the particular part of the brain you want to stimulate and that means that you have to use a stereotaxic frame. The patient is anaesthetized and the frame is attached to his head; this enables the surgeon to target his electrode to any point deep within the head, which can be defined by x, y & z coordinates (width, fore and aft and depth) in relation to the points by which the frame is attached to the patient’s skull. Then he does an MRI scan to find which coordinates he needs to use for that particular patient for the target he’s chosen, as there is great variability between individuals. He then makes a small hole through the scalp and skull.

Molecular Neurogeneticist David Rubinsztein on neurodegenerative diseases, tetrabenazine, and aggregate-prone proteins
After this the patient is woken up because the surgeon needs to ask the patient to answer questions and make movements during the next stage. He uses a computer program to direct the electrode to his chosen point. He then advances the electrode to that point and begins stimulating to find out whether this alleviates the problems. Getting control over the symptoms happens when the stimulation current is sufficient to entrain the ongoing electrical activity in the basal ganglia in such a way that it is no longer oscillating spontaneously out of control. In Parkinson’s tremor, for instance, the tremor is caused by pathological synchronization of the electrical activity in the basal ganglia. If the surgeon can get rid of this synchronisation then she can eliminate the tremor. What the DBS does is to entrain the neurons to its stimulation frequency, which tends to be quite high, 150 times a second, so that the damaging tremor synchronisation cannot take place.

Applications of DBS

The most common indication for DBS is Parkinson’s disease. In most patients with Parkinson’s disease we start of with the usual treatment which is L-DOPA. It treats the condition pretty well for a few years, but very often the worst movement disorders return and it is then that DBS can get rid of them. There are a lot of other potential uses for DBS however. For instance: tremor has many other possible causes than Parkinson’s disease. DBS can get rid of most of these. Then there is a common complication of Parkinson’s disease and also a disease in its own right called dystonia which is where muscles, typically in the neck, contract when they shouldn’t. Such head twists can be alleviated by DBS.

 L-DOPA / Wikimedia Commons

L-DOPA / Wikimedia Commons

Even though it is most widely used for Parkinson’s disease, tremor and dystonia, there are a lot of other conditions that are now being researched. One of the most well developed is for intractable epilepsy. Another common condition which DBS looks like being able to solve is chronic pain. For instance, if you have an amputation, very often the missing leg becomes very painful and DBS can often help that.

Now people are seriously thinking that it may work for depression. It’s also been used to treat addiction and to treat obsessive-compulsive disorders. It’s even been used for anorexia and conversely people are claiming that it might be useful to overcome serious obesity, by modulating people’s hunger mechanism in the hypothalamus. It has even been claimed to improve memory in Alzheimer’s disease. These are all uses of DBS that are under research at the moment. However, the potential uses of DBS are even greater than this. Because the brain works electrically, if one coould set right the disordered electrical activity that is causing symptoms precisely where this is happening, then DBS could be extended to a myriad other conditions.


Side Effects

There are always side effects for any drug or medical intervention however. First there are the possible complications of the anaesthesia and the surgery itself. You have to put an electrode through the scalp and skull into the brain which can cause infections or bleeding. Obviously there is some damage caused by the electrode going through the brain. Usually this is very slight, but occasionally it can burst an important blood vessel and thereby cause extensive damage, but this is very rare (about 1/1000).

In addition there are potential side effects of the actual DBS. These are more difficult to estimate. For instance, we know that Parkinson’s patients sometimes resort to suicide because getting this disease is of course very depressing. Some patients do commit suicide after undergoing DBS, but this is probably less common than suicide in PD patients who have not had DBS. Nevertheless it has been claimed that the suicide might be a side effect of the DBS itself which is indeed a theoretical possibility because the basal ganglia also play a part in controlling emotions. Conversely there is now some evidence that DBS in other structures can actually alleviate depression, hence suicide. Then there are more dramatic adverse side effects of basal ganglia, such as hypersexuality or pathological gambling, but again these are things that occur in some Parkinson’s patients anyway, and again have not been shown to be particularly associated with DBS.

Future Directions

There are a number of ways DBS is likely to develop. At the moment the pattern of stimulation used is very stereotyped; but in the future we will be able to use feedback from the stimulated area to adapt the stimulation to provide the optimum pattern to alleviate that particular patient’s problems; this is called ‘demand pacing’.

It is almost certain, that some patients with very severe depression, and in other psychiatric conditions, may gain benefit from DBS. The questions remain: which patients will benefit? And which are the best targets? There are various different places in the brain that we can stimulate which could help these problems. We don’t know which are the best however, and that’s true for other conditions which we believe we can help, for example, pathological pain or many kinds of epilepsy or many other diseases. We need to know where is the best place to stimulate for each condition and we need to determine in which patients that stimulation will work best – at the moment we simply don’t know.

Neuroscientist Karl Friston on the Markov blanket, Bayesian model evidence, and different global brain theories
The brain works electrically and therefore in the longer term there is a great future for being able to target electrical remediation of pathological activity in precisely the right places in each individual brain. DBS has a very bright future; it’s likely to be able to target pathology much more accurately than drugs. We will be able to do so, because most neuroactive drugs target all the receptors that are responding to a particular transmitter in the brain. Even if you’ve got a drug like L-DOPA that replaces dopamine in the part of the brain that goes wrong in Parkinson’s disease, it will unfortunately also affect dopamine transmission in all the other parts of the brain, and that’s what gives rise to the many side effects. On the other hand precisely targeted DBS will be able to avoid those problems.

Open Question

The big open question is whether we will ever be able to modulate electrical activity deep in the brain without having to bore a hole in the head. People don’t usually want cranial surgery because it sounds very dangerous, and it definitely does carry risks. What I hope is what we will be able to develop means of stimulating deep in the brain without having to stick electrodes through the skull and the brain. But it will require great advances in the physics of delivering energy through the skull to precisely the right places in the brain.

Emeritus Professor of Physiology, Department of Physiology, Anatomy and Genetics
Did you like it? Share it with your friends!
    Published items
    To be published soon

    Most viewed

  • 1
    David E. Nichols
  • 2
    Steven Brams
  • 3
    Klaus Linkenkaer-Hansen
  • 4
    Stephen Read
  • 5
    Nicholas Evans
  • 6
    Richard Parkinson
  • 7
    Barbara Sahakian
  • 8
    Mark Mattson
  • 9
    John Krystal
  • New